290 related articles for article (PubMed ID: 18984419)
1. Issues related to clinical trials of oral and biologic disease-modifying agents for Sjögren's syndrome.
Carsons SE
Rheum Dis Clin North Am; 2008 Nov; 34(4):1011-23, x. PubMed ID: 18984419
[TBL] [Abstract][Full Text] [Related]
2. Infliximab and primary Sjogren's syndrome: comment on the article by Mariette et al.
Fresko I; Seyahi E; Yurdakul S
Arthritis Rheum; 2004 Dec; 50(12):4077; author reply 4077-8. PubMed ID: 15593208
[No Abstract] [Full Text] [Related]
3. Recognition and management of Sjögren's syndrome: strategies for the advanced practice nurse.
Vale DL
Nurs Clin North Am; 2000 Mar; 35(1):267-78. PubMed ID: 10673580
[TBL] [Abstract][Full Text] [Related]
4. Will targeting B cells be the answer for Sjögren's syndrome?
Looney RJ
Arthritis Rheum; 2007 May; 56(5):1371-7. PubMed ID: 17469093
[No Abstract] [Full Text] [Related]
5. A double blind placebo controlled trial of azathioprine in the treatment of primary Sjögren's syndrome.
Price EJ; Rigby SP; Clancy U; Venables PJ
J Rheumatol; 1998 May; 25(5):896-9. PubMed ID: 9598887
[TBL] [Abstract][Full Text] [Related]
6. First report of improvement of coeliac disease in a patient with Sjögren's syndrome treated with rituximab.
Nikiphorou E; Hall FC
Rheumatology (Oxford); 2014 Oct; 53(10):1906-7. PubMed ID: 24729401
[No Abstract] [Full Text] [Related]
7. [Sjögren's syndrome: a new approach to treatment].
Rossier V; Bart PA; Spertini F
Rev Med Suisse; 2012 Apr; 8(337):843-7. PubMed ID: 22594008
[TBL] [Abstract][Full Text] [Related]
8. Articular manifestations in primary Sjögren's syndrome: clinical significance and prognosis of 188 patients.
Fauchais AL; Ouattara B; Gondran G; Lalloué F; Petit D; Ly K; Lambert M; Launay D; Loustaud-Ratti V; Bezanahari H; Liozon E; Hachulla E; Jauberteau MO; Vidal E; Hatron PY
Rheumatology (Oxford); 2010 Jun; 49(6):1164-72. PubMed ID: 20299380
[TBL] [Abstract][Full Text] [Related]
9. Primary Sjogren's syndrome: current and prospective therapies.
Thanou-Stavraki A; James JA
Semin Arthritis Rheum; 2008 Apr; 37(5):273-92. PubMed ID: 17714766
[TBL] [Abstract][Full Text] [Related]
10. Treatment Guidelines for Rheumatologic Manifestations of Sjögren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain.
Carsons SE; Vivino FB; Parke A; Carteron N; Sankar V; Brasington R; Brennan MT; Ehlers W; Fox R; Scofield H; Hammitt KM; Birnbaum J; Kassan S; Mandel S
Arthritis Care Res (Hoboken); 2017 Apr; 69(4):517-527. PubMed ID: 27390247
[TBL] [Abstract][Full Text] [Related]
11. Management of patients presenting with Sjogren's syndrome.
Venables PJ
Best Pract Res Clin Rheumatol; 2006 Aug; 20(4):791-807. PubMed ID: 16979538
[TBL] [Abstract][Full Text] [Related]
12. Progress and regression within primary Sjögren's syndrome.
Manthorpe R; Bredberg A; Henriksson G; Larsson A
Scand J Rheumatol; 2006; 35(1):1-6. PubMed ID: 16467033
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of Sjogren's syndrome with rituximab.
Touma Z; Sayad J; Arayssi T
Scand J Rheumatol; 2006; 35(4):323-5. PubMed ID: 16882600
[No Abstract] [Full Text] [Related]
14. Infliximab in primary Sjögren's syndrome: one-year followup.
Steinfeld SD; Demols P; Appelboom T
Arthritis Rheum; 2002 Dec; 46(12):3301-3. PubMed ID: 12483735
[TBL] [Abstract][Full Text] [Related]
15. Biologics in Sjögren's syndrome.
Skarlis C; Marketos N; Mavragani CP
Pharmacol Res; 2019 Sep; 147():104389. PubMed ID: 31415917
[TBL] [Abstract][Full Text] [Related]
16. Sjögren Syndrome: Why Do Clinical Trials Fail?
Fox RI; Fox CM
Rheum Dis Clin North Am; 2016 Aug; 42(3):519-30. PubMed ID: 27431352
[TBL] [Abstract][Full Text] [Related]
17. Aquaporins in primary Sjögren's syndrome: comment on the articles by Steinfeld et al.
Waterman SA; Beroukas D; Hiscock J; Jonsson R; Gordon TP
Arthritis Rheum; 2003 Apr; 48(4):1167-8. PubMed ID: 12687572
[No Abstract] [Full Text] [Related]
18. Primary Sjögren's syndrome: new clinical and therapeutic concepts.
Ramos-Casals M; Tzioufas AG; Font J
Ann Rheum Dis; 2005 Mar; 64(3):347-54. PubMed ID: 15498797
[TBL] [Abstract][Full Text] [Related]
19. Sjögren Syndrome in the Twenty-First Century.
Scofield RH
Rheum Dis Clin North Am; 2016 Aug; 42(3):xiii-xiv. PubMed ID: 27431355
[No Abstract] [Full Text] [Related]
20. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab.
Meiners PM; Arends S; Brouwer E; Spijkervet FK; Vissink A; Bootsma H
Ann Rheum Dis; 2012 Aug; 71(8):1297-302. PubMed ID: 22258489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]